In this video, Beth Faiman, a nurse practitioner at the Cleveland Clinic emphasizes the importance of a shared decision-making process in multiple myeloma, one that involves both patients and providers. She explains that when patients are provided with information on eligible clinical trials and standard therapies, it allows them to make informed choices about their treatment. Research indicates that this method leads to better treatment adherence, longer treatment duration, and stronger trust between patients and their healthcare team.

Reference: Faiman B. The importance of shared decision making in multiple myeloma. YouTube. Updated October 12, 2022. Accessed December 14, 2023. https://www.youtube.com/watch?v=2oAR3Rob_gc